Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy 2024-11-25 09:30
Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss 2024-11-06 15:41
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) 2024-04-24 09:27
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
Hanmi Fine Chemical Launches 'high-tech CDMO' Business 2022-05-23 08:32
Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide" 2021-06-29 21:00
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs 2021-01-18 22:00
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine) 2021-01-13 09:00
1